TherapeuticsMD
TXMD
#10731
Rank
A$29.9 M
Marketcap
A$2.58
Share price
-5.52%
Change (1 day)
-6.27%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2026 (TTM): A$0.12

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is A$0.12. In 2021 the company made an earnings per share (EPS) of A-$32.78 an increase over its 2020 EPS that were of A-$50.61.

EPS history for TherapeuticsMD from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$0.12
2021A-$32.78-35.22%
2020A-$50.61-5.63%
2019A-$53.6320.34%
2018A-$44.5755.26%
2017A-$28.71-19.15%
2016A-$35.50-6%
2015A-$37.7742.86%
2014A-$26.4452.17%
2013A-$17.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.07 787.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.84 7,214.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
A-$5.85-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
A$2.31 1,811.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
A-$38.19-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA